Posts by Sandra Ansanay-Alex
NewBiologix is betting on the industrialization of gene therapy
With CHF 45 million raised, the start-up NewBiologix, officially launched on 11 May 2023 at the Biopôle in Epalinges, has very high ambitions. Its two founders, Igor Fisch and Nicolas Mermod, want to reproduce the model that they had successfully implemented in Geneva with their previous company, Selexis. NewBiologix SA emerged from stealth…
Read MoreNovostia raises € 2.5 Million
Novostia SA is a clinical stage company developing a breakthrough artificial heart valve. Founded in April 2017, in Neuchâtel, Novostia announced it has just raised an additional 2.5 million euros. The total funds raised since its foundation amount to just over 15 million included public subsidies from the European Union and the Canton of…
Read MoreBioAlps 20th General Assembly
Collaboration is key to foster innovation in the Swiss Health Valley Founded in 2003, BioAlps empowers the Swiss Health Valley and is Western Switzerland life sciences cluster. For the 20 past years, cantons and academic institutions have been working to make the development of life sciences a priority. This is why our region has…
Read MoreNobel Laureate Prof. James Rothman and Drug Discovery Expert Dr. John Baldoni join Gnubiotics as Senior Advisors
The Swiss company has been able to recreate the unique diversity of glycan structures found in breast milk, nature’s perfect food, and has developed a broadening pipeline of product candidates to boost the microbiome. Swiss biotech Gnubiotics Sciences SA, a pioneering company in glyco-immunology research to develop human therapeutics, announced the appointment of…
Read MoreHealthCare Konnect and Ligence Partners to Expand Access to AI-based Echocardiography Solution
The two companies join forces to bring AI-based echocardiography solution, Ligence Heart, in Switzerland and North Africa (Morocco, Algeria, Tunisia & Egypt). HealthCare Konnect, a Swiss company specialized in the distribution of AI-based diagnostic solutions, and Ligence, a Lithuanian leading provider of healthcare technology solutions, have announced a strategic distribution partnership to bring…
Read MoreDomo Health partners with SAK to bring advanced digital health solutions at home
SAK (St. Gallisch-Appenzellische Kraftwerke AG) has acquired a participation in Domo Health as part of a round of capital raising. Together, Domo Health and SAK will expand an offer promoting digital health in private households. Domo Health, a leading company in the field of digital health based at EPFL Innovation Park, has entered into…
Read MoreBiotech companies thrive in Switzerland
Swiss Biotech Report 2023 shows sector weathers global disruption well and continues to play a leading role driving global healthcare innovation Record revenues of CHF 6.8 billion (USD 7.5 billion) Fundraising of CHF 1.3 billion (USD 1.5 billion) exceeding pre-COVID 19 levels of 2019. CHF 0.78 billion by public companies, CHF 0.55 billion…
Read MoreImpossible Materials raises CHF 3,4 Million
Suspected of causing cancer, titanium dioxide, a white colouring agent, has been banned from food in Switzerland and Europe since last year. Impossible Materials, a spin-off from the University of Fribourg, has just raised CHF 3.4 million to develop a cellulose-based alternative. The round, which was led by Mission Possible Capital, was supported by Big Idea…
Read MoreGeorge Coukos honored by the American Association for Cancer (AACR)
George Coukos, full professor at the Faculty of Biology and Medicine of UNIL, director of the Department of Oncology UNIL-CHUV and of the Ludwig Institute for Cancer Research Lausanne, is one of the 23 world personalities to be received as Fellow of the Academy of the prestigious American association Prof. George Coukos, who…
Read MoreDistalmotion raises $ 150M
The fundraise, led by Revival Healthcare Capital, will be used to get a Food and Drug Administration (FDA) approval for Dexter, Distalmotion’s robotic surgery device. Dexter, Distalmotion’s robotic platform, is already in day-to-day clinical use in Europe, successfully treating patients across a multitude of complex and high-volume procedures in general surgery, gynecology, urology. This…
Read More